Updated
HumacyteHUMA · Healthcare
$0.45+13.13%
Market cap$124M
IndustryBiotechnology

Humacyte (HUMA) Superinvestor holders

7 of the superinvestors we track hold Humacyte (HUMA) in their latest 13F filings, $7M in total.

Summary

The largest holder is Tony Yoseloff (Davidson Kempner Capital Management), with $4M, 0.1% of the portfolio.

In their latest quarter: 3 opened a new position, 1 added, 1 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Tony Yoseloff
Davidson Kempner Capital Management
New position 5,000,000$4M 0.1%Q2 2026
Cliff Asness
AQR Capital Management
Added 2,597,134$2M 0.0%Q2 2026
Didric Cederholm
Lion Point Capital
Held 650,000$507,260 2.4%Q2 2026
Paul Marshall
Marshall Wace
New position 181,831$141,829 0.0%Q2 2026
Steve Cohen
Point72 Asset Management
New position 53,728$41,929 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 29,548$23,059 0.0%Q2 2026
Paul Tudor Jones
Tudor Investment Corp
Held 12,300$9,599 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 20267
Q1 20264
Q4 20255
Q3 20255
Q2 20256
Q1 20256
Q4 20245
Q3 20248

Questions about Humacyte

Which superinvestors own Humacyte?

7 of the superinvestors we track hold Humacyte (HUMA) in their latest 13F filings, $7M in total. Tony Yoseloff, Cliff Asness, Didric Cederholm, Paul Marshall, Steve Cohen, Two Sigma.

Who is the largest superinvestor holder of HUMA?

The largest holder is Tony Yoseloff (Davidson Kempner Capital Management), with $4M, 0.1% of the portfolio.

From Humacyte's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Humacyte and thousands of other companies, in one place. Free to start.